CoChat

Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases

Open access
Wen, Yankai, Ma, Lichun, Ju, Cynthia · 2023 · eGastroenterology

The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.

Abstract

Viral hepatitis, alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are the three major causes of chronic liver diseases, which account for approximately 2 million deaths per year worldwide. The current direct-acting antiviral drugs and vaccinations have effectively reduced and ameliorated viral hepatitis infection, but there are still no effective drug treatments for ALD, NAFLD and liver cancer due to the poor understanding of their pathogenesis. To better understand the pathogenesis, the fifth Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Annual Symposium, which was held virtually on 21–22 October 2022, focused on the topics related to ALD, NAFLD and liver cancer. Here, we briefly highlight the presentations that focus on the current progress in basic and translational research in ALD, NAFLD and liver cancer. The roles of non-coding RNA, autophagy, extrahepatic signalling, macrophages, etc in liver diseases are deliberated, and the application of single-cell RNA sequencing in the study of liver disease is also discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/egastro-2023-100020

Cites

137 of 138 references verified0 citation errors · 1 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 138 references

Research works printed but not linked: 1

  1. Ma, 2022, Mitochondrial dynamics and stasis are critical for hepatocyte function and liver tumorigenesis, Hepatology, 76, S168

Cited by

See all 34

Metadata

Authors
Wen, Y., Ma, L., & Ju, C.
Affiliations
  • Department of Anesthesiology, Critical Care and Pain Medicine, University of Texas McGovern Medical School, Houston, Texas, USA
  • National Cancer Institute (US)
Corresponding author
Ju, Cynthia
Venue
eGastroenterology
Publisher
BMJ
Published
2023-10
Volume
1
Issue
2
Pages
e100020
ISSN
  • 2766-0125 (ISSN-L)
  • 2976-7296
OpenAlex
W4387784557
Cited by
31
References
137
Citations by year
2026: 11 · 2025: 16 · 2024: 3 · 2023: 1
FWCI
6.19
Type
journal article
Language
en
Open access
Locations
  • eGastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Center for Cancer Research, National Cancer Institute (ZIA BC 012079, ZIA BC 012083)
  • National Institutes of Health (DK121330, DK122708, DK122796)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
chronic liver disease, alcoholic liver disease, non-alcoholic fatty liver disease, viral hepatitis, liver cancer, pathogenesis, therapeutic target, non-coding RNA, autophagy, macrophages, single-cell RNA sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases. https://app.cochat.ai/papers/10.1136/egastro-2023-100020
The paper
Wen, Y., Ma, L., & Ju, C. (2023). Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases. eGastroenterology. https://doi.org/10.1136/egastro-2023-100020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.